Open access
Open access
Powered by Google Translator Translator

Chest Medicine (all articles)

It’s not just SARS-CoV-2: Most respiratory viruses spread by aerosols.

27 Aug, 2021 | 10:18h | UTC

It’s not just SARS-CoV-2: Most respiratory viruses spread by aerosols – University of California – San Diego

Original article: Airborne transmission of respiratory viruses – Science

 

Commentary on Twitter (thread – click for more)

 


[Press release – not published yet] Study shows vaccine protection wanes over time, but vaccines still offer good protection against severe disease.

27 Aug, 2021 | 10:11h | UTC

Press release: Is COVID vaccine protection fading? – ZOE Covid Study

Commentaries:

Covid infection protection waning in double jabbed – BBC

Expert reaction to press release from the ZOE app on vaccine effectiveness over time – Science Media Centre

 


Cohort study: Most COVID-19 hospital survivors had a good physical and functional recovery after 1 year of follow-up, but around half of the patients had at least one sequelae symptom.

27 Aug, 2021 | 10:13h | UTC

1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study – The Lancet

Editorial: Understanding long COVID: a modern medical challenge – The Lancet

Related:

M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)

New guidelines to help doctors manage long COVID patients published.

The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.

 


[Preprint] Observational data suggests natural immunity after a SARS-CoV-2 infection confers longer lasting and stronger protection compared to vaccine-induced immunity.

27 Aug, 2021 | 10:16h | UTC

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections – medRxiv

Commentary: Having SARS-CoV-2 once confers much greater immunity than a vaccine—but no infection parties, please – Science

 

Commentary on Twitter (thread – click for more)

 


Covid-19 vaccines flirted with perfection at first. Reality is more complicated.

27 Aug, 2021 | 10:05h | UTC

Covid-19 vaccines flirted with perfection at first. Reality is more complicated – STAT

 

Commentary on Twitter

 


COVID-19 associated Mucormycosis: risk factors and mechanisms of disease.

27 Aug, 2021 | 10:07h | UTC

COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease – Clinical Infectious Diseases

Related: Clinical Picture: Mucormycosis after COVID-19 in a patient with diabetes. (several articles on the subject)

 

Commentary on Twitter

 


Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

26 Aug, 2021 | 09:16h | UTC

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting – New England Journal of Medicine

Commentaries on Twitter

(thread from the author – click for more)

 


WHO Guide | Support for rehabilitation: self-management after COVID-19-related illness.

26 Aug, 2021 | 09:21h | UTC

Support for rehabilitation: self-management after COVID-19-related illness, 2nd ed. – World Health Organization

 

Commentary on Twitter

 


Johnson & Johnson booster shot prompts large increase in immune response, company says.

26 Aug, 2021 | 09:14h | UTC

Johnson & Johnson booster shot prompts large increase in immune response, company says – CNN

News release: Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine

 


The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.

26 Aug, 2021 | 08:59h | UTC

The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease – The Lancet Respiratory Medicine

Invited commentary: Charting a course for the management of long COVID

Related: M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)

 

Commentary on Twitter

 


New guidelines to help doctors manage long COVID patients published.

26 Aug, 2021 | 09:01h | UTC

New guidelines to help doctors manage long COVID patients published – Imperial College London

Original article: Recommendations for the recognition, diagnosis, and management of long covid: A Delphi study – British Journal of General Practice

Related: M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)

 


CDC Report: Unvaccinated 5 times more likely to get COVID-19 and 29 times more likely to be hospitalized than vaccinated individuals.

25 Aug, 2021 | 09:56h | UTC

SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status — Los Angeles County, California, May 1–July 25, 2021 – CDC Morbidity and Mortality Weekly Report

Commentary: CDC: Unvaccinated 5 times more likely to get COVID-19 – CIDRAP

 

Commentary on Twitter

 


What we actually know about the vaccines and the delta variant – “Covid-19 vaccines still are effective in preventing hospitalization. But vaccinated people are more likely to get sick than before”.

25 Aug, 2021 | 09:09h | UTC

What we actually know about the vaccines and the delta variant – Vox

 


CDC Report: Vaccine effectiveness dropped from 91% to 66% since the SARS-CoV-2 Delta variant became predominant.

25 Aug, 2021 | 09:11h | UTC

Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021 – CDC Morbidity and Mortality Weekly Report

Commentaries:

Vaccines are less protective against Delta infection but still reduce risk by two-thirds, US CDC study shows – CNN

Messenger RNA COVID vaccines 66% effective against Delta: US study – Associated Press

 


Perspective | Delta has changed the pandemic risk calculus – “If you’re confused about what you can do right now, you should be”.

25 Aug, 2021 | 09:05h | UTC

Delta Has Changed the Pandemic Risk Calculus – The Atlantic

 


Third Pfizer dose 86% effective in over 60s, Israeli HMO says.

25 Aug, 2021 | 09:01h | UTC

Third Pfizer dose 86% effective in over 60s, Israeli HMO says – Reuters

 

Commentary on Twitter

 


Perspective | That ‘damn machine’: the dark side of mechanical ventilators in the ICU.

25 Aug, 2021 | 09:04h | UTC

That ‘damn machine’: the dark side of mechanical ventilators in the ICU – STAT

 


Covid-19 booster vaccines: What we know and who’s doing what.

24 Aug, 2021 | 10:04h | UTC

Covid-19 booster vaccines: What we know and who’s doing what – The BMJ

 


[Preprint] RCT: Fluvoxamine reduced the risk for ER visits and hospitalization among patients with Covid-19.

24 Aug, 2021 | 10:06h | UTC

RCT: Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19 – Together Clinical Trials

Related:

Opinion | Could this be our first effective, inexpensive, widely available outpatient treatment for COVID-19? (It’s fluvoxamine).

Preliminary study shows fluvoxamine may reduce clinical deterioration in outpatients with symptomatic COVID-19

 

Commentary on Twitter

 


How will Delta evolve? Here’s what the theory tells us.

24 Aug, 2021 | 09:58h | UTC

How will Delta evolve? Here’s what the theory tells us – The Conversation

 


Opinion | The FDA really did have to take this long – “If vaccine approval feels maddeningly scrupulous, that’s because the alternative is worse”.

24 Aug, 2021 | 10:01h | UTC

The FDA Really Did Have to Take This Long – The Atlantic

 


How I Do It: Considering lung transplantation for patients with COVID-19.

24 Aug, 2021 | 09:55h | UTC

How I Do It: Considering lung transplantation for patients with COVID-19 – CHEST

 

Related:

Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries

Report: Lung transplantation for 3 patients with severe COVID-19

 


COVID vaccines protect against Delta, but their effectiveness wanes.

24 Aug, 2021 | 09:57h | UTC

COVID vaccines protect against Delta, but their effectiveness wanes – Nature

Original study: [Preprint] Pfizer vaccine effectiveness against Delta declines faster than AstraZeneca, both offering the same protection after 4 months.

 


M-A: Patient–ventilator asynchrony, impact on clinical outcomes and effectiveness of interventions.

24 Aug, 2021 | 08:51h | UTC

Patient–ventilator asynchrony, impact on clinical outcomes and effectiveness of interventions: a systematic review and meta-analysis – Journal of Intensive Care

 


Among patients receiving mRNA vaccines, clinically significant symptoms were more frequent following dose 2, following dose 1 in patients with previous SARS-CoV-2 infection, and in those who received the Moderna vaccine.

22 Aug, 2021 | 23:54h | UTC

Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers – JAMA Internal Medicine

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.